Novartis AG
PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF
Last updated:
Abstract:
The present disclosure provides a process for concentrating proteins including an ultrafiltering, a diafiltering, and a second ultrafiltering sequence, at elevated temperatures, such as above about 30.degree. C. The disclosure also includes a process for preparing highly concentrated antibody compositions, and highly concentrated antibody products.
Status:
Application
Type:
Utility
Filling date:
10 Sep 2020
Issue date:
1 Apr 2021